Navigation Links
Research yields new clues to how brain cancer cells migrate and invade
Date:5/1/2012

Researchers have discovered that a protein that transports sodium, potassium and chloride may hold clues to how glioblastoma, the most common and deadliest type of brain cancer, moves and invades nearby healthy brain tissue. The findings, reported 1 May in the online, open-access journal PLoS Biology, also suggest that a cheap FDA-approved drug already on the market could slow movement of glioblastoma cells.

"The biggest challenge in brain cancer is the migration of cancer cells. We can't control it," says study leader Alfredo Quinones-Hinojosa, M.D., an associate professor of neurosurgery and oncology at the Johns Hopkins University School of Medicine. "If we could catch these cells before they take off into other parts of the brain, we could make malignant tumors more manageable, and improve life expectancy and quality of life. This discovery gives us hope and brings us closer to a cure."

Glioblastoma, which is diagnosed in roughly 10,000 Americans each year, is so aggressive that the average life expectancy after diagnosis is just 15 months, Quinones says. The cancer spreads to healthy brain tissue so quickly and completely that surgical cures are virtually impossible and advances in radiation and chemotherapy have been slow in coming.

In a search for ways to prevent or limit the spread, and stop lethal recurrence of the tumor, the researchers focused on a protein called NKCC1 in human tumor cells in the laboratory and also in tumor cells injected into mice. NKCC1 exchanges sodium, potassium and chloride ions, together with water and regulates cell volume.

Quinones-Hinojosa and his team found that cells with more NKCC1 appear to move farther because the protein made it easier for tumor cells to propel themselves through tissue. The more of this protein in the tumor cell, they discovered, the faster the glioblastoma cells were able to travel. When NKCC1 was absent, they noted that the cells had larger focal adhesions, which allow the cells to attach to surrounding cells. Larger adhesions, he says, appear to keep the cells more anchored in place, while smaller ones made cells more mobile and allowed for more migration.

In their experiments, the researchers blocked the protein and were able to slow the migration of the tumor cells. Less mobility, Quinones-Hinojosa says, means less invasion of surrounding tissue.

To block the channel, the team used the diuretic bumetanide, a simple water pill routinely used to reduce swelling and fluid retention. Added to either tumor cells in the laboratory, or to human tumor cells in mice, the drug blocked the NKCC transporter and slowed the pace of cell movement. If the cells were made less invasive, Quinones notes, tumors would be easier to surgically remove.

The researchers were also able to correlate human tumor grade with levels of NKCC1. The less aggressive the tumor, they discovered, the smaller the amount of the protein present in the cells. This suggests that NKCC1 may not only contribute to the increased invasiveness of tumors, but also serve as a potential marker for diagnosis.


'/>"/>
Contact: Rachel Jarmy
rjarmy@plos.org
44-122-344-2837
Public Library of Science
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2019)... ... June 13, 2019 , ... ... (AM)-enabled tissue fabrication, patient-matched models and surgical guides, and prosthetics and assistive ... improve patient care. Children with birth defects, soldiers with cranial injuries, conjoined ...
(Date:6/12/2019)... ... 12, 2019 , ... GlucoseZone , the first-ever clinically ... that LaurieAnn Scher, MS, RD, CDE GlucoseZone’s Chief Strategy Officer, has been ... the Year 2019, honoring best-in-class learning and development initiatives within the diabetes community. ...
(Date:6/12/2019)... ... June 12, 2019 , ... In September of 2018, NVNA and ... telehealth and remote patient monitoring. Following its full-scale launch in March, NVNA has expanded ... Since the beginning of 2019, NVNA has achieved an average all-cause hospital readmissions rate ...
(Date:6/12/2019)... ... 12, 2019 , ... The HACCP SmartStep2 Walk-Through Dual ... Sanitizers’ HACCP Footwear Sanitizing Unit equipment. The HACCP SmartStep2 adds an additional layer ... labs, and clean rooms by reducing cross-contamination from footwear before employees enter the ...
(Date:6/11/2019)... ... June 11, 2019 , ... Homecare Homebase (HCHB), the nation’s ... Cycle Management (RCM) service at the company’s annual Users Conference this week in ... HCHB Services Suite, a collection of technology-enabled services designed to alleviate the burden ...
Breaking Medicine News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... The National Comprehensive ... Chemotherapy Order Templates ( NCCN Templates ®) into the CureMD Oncology EHR to ... NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). , “The collaboration with CureMD ...
(Date:6/6/2019)... ... June 06, 2019 , ... MEDICC (Medical Education Cooperation with Cuba) has ... “This latest move is one more assault on the freedom of Americans, Cuban-Americans and ... Chair of MEDICC’s Board of Directors. , MEDICC has long stood for open ...
(Date:6/6/2019)... ... 05, 2019 , ... Cobb-Vantress, Inc. / Siloam Springs, Arkansas, ... avian influenza virus from replicating in lab-grown chicken cells, suggesting that it may ... The study was funded by Biotechnology and Biological Sciences Research Council with additional ...
Breaking Medicine Technology: